Literature DB >> 21245799

B-type natriuretic peptide levels and continuous-flow left ventricular assist devices.

Basar Sareyyupoglu1, Barry A Boilson, Lucian A Durham, Christopher G A McGregor, Richard C Daly, Margaret M Redfield, Brooks S Edwards, Robert P Frantz, Naveen L Pereira, Soon J Park.   

Abstract

We postulated that postoperative B-type natriuretic peptide (BNP) levels would be reflective of the degree of hemodynamic support rendered by various pump speeds settings (RPM) of continuous-flow left ventricular assist devices (LVADs). Twenty LVAD patients were evaluated prospectively (Jarvik 2000: n = 9, HeartMate II: n = 11). The mean age was 57.7 ± 14.9 years, and 14 were male. B-type natriuretic peptide levels were drawn while the patients were supported on LVADs at variable RPM settings. The RPM settings were correlated with the changes in BNP levels. Eleven patients underwent LVAD implantation for a lifelong support while the rest were as a bridge therapy to transplantation. Four patients required LVAD change out for various causes of pump failure. Postoperative BNP levels decreased dramatically with the initiation of LVAD support. The levels correlated inversely with the degree of hemodynamic support rendered at various RPM settings of the HeartMate II (p < 0.001). Overall, BNP levels decreased significantly in 2 days after RPM increase. We observed a significant inverse correlation between the postoperative BNP levels and the degree of LVAD support. The effective LVAD support seems to result in a marked reduction in BNP levels, and monitoring serial BNP levels may be helpful in managing patients supported on continuous LVAD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21245799     DOI: 10.1097/MAT.0b013e3181f127a7

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  7 in total

1.  Cellular, molecular, genomic changes occurring in the heart under mechanical circulatory support.

Authors:  Michele Gallo; Vincenzo Tarzia; Laura Iop; Jonida Bejko; Giacomo Bortolussi; Roberto Bianco; Tomaso Bottio; Gino Gerosa
Journal:  Ann Cardiothorac Surg       Date:  2014-09

2.  Diagnosis and Management of LVAD Thrombosis.

Authors:  Edo Y Birati; J Eduardo Rame
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-02

3.  Background and design of the profiling biobehavioral responses to mechanical support in advanced heart failure study.

Authors:  Christopher S Lee; James O Mudd; Jill M Gelow; Thuan Nguyen; Shirin O Hiatt; Jennifer K Green; Quin E Denfeld; Julie T Bidwell; Kathleen L Grady
Journal:  J Cardiovasc Nurs       Date:  2014 Sep-Oct       Impact factor: 2.083

4.  [Congestive heart failure: reverse cardiac remodeling mediated by left ventricular assist devices].

Authors:  J Wohlschläger; H Milting; J Stypmann; T Hager; C Schmid; B Levkau; H A Baba
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

5.  Evidence for synergy between sarcomeres and fibroblasts in an in vitro model of myocardial reverse remodeling.

Authors:  Shi Shen; Lorenzo R Sewanan; Stuart G Campbell
Journal:  J Mol Cell Cardiol       Date:  2021-05-14       Impact factor: 5.763

Review 6.  N-terminal pro B type natriuretic peptide in high cardiovascular-risk patients for noncardiac surgery: What is the current prognostic evidence?

Authors:  Anita K Malhotra; Harish Ramakrishna
Journal:  Ann Card Anaesth       Date:  2016 Apr-Jun

7.  Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device.

Authors:  Andrew C Morley-Smith; Adam Mills; Steven Jacobs; Bart Meyns; Filip Rega; André R Simon; John R Pepper; Alexander R Lyon; Thomas Thum
Journal:  Eur J Heart Fail       Date:  2014-06-24       Impact factor: 15.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.